[go: up one dir, main page]

HUE066812T2 - Az utidelone szilárd, orális készítménye - Google Patents

Az utidelone szilárd, orális készítménye

Info

Publication number
HUE066812T2
HUE066812T2 HUE21863656A HUE21863656A HUE066812T2 HU E066812 T2 HUE066812 T2 HU E066812T2 HU E21863656 A HUE21863656 A HU E21863656A HU E21863656 A HUE21863656 A HU E21863656A HU E066812 T2 HUE066812 T2 HU E066812T2
Authority
HU
Hungary
Prior art keywords
utidelone
solid oral
oral formulation
formulation
solid
Prior art date
Application number
HUE21863656A
Other languages
English (en)
Inventor
Li Tang
Chuan Zhang
Rongguo Qiu
Original Assignee
Beijing Biostar Pharmaceuticals Co Ltd
Chengdu Biostar Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Biostar Pharmaceuticals Co Ltd, Chengdu Biostar Pharmaceuticals Ltd filed Critical Beijing Biostar Pharmaceuticals Co Ltd
Publication of HUE066812T2 publication Critical patent/HUE066812T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE21863656A 2020-09-02 2021-09-02 Az utidelone szilárd, orális készítménye HUE066812T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010910072 2020-09-02

Publications (1)

Publication Number Publication Date
HUE066812T2 true HUE066812T2 (hu) 2024-09-28

Family

ID=80492210

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE21863656A HUE066812T2 (hu) 2020-09-02 2021-09-02 Az utidelone szilárd, orális készítménye

Country Status (12)

Country Link
US (1) US20230048901A1 (hu)
EP (1) EP4062913B1 (hu)
JP (1) JP7536098B2 (hu)
KR (1) KR20230024389A (hu)
CN (1) CN114727995B (hu)
AU (1) AU2021337086B2 (hu)
BR (1) BR112023003572A2 (hu)
CA (1) CA3184960A1 (hu)
ES (1) ES2981041T3 (hu)
HU (1) HUE066812T2 (hu)
PL (1) PL4062913T3 (hu)
WO (1) WO2022048592A1 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024139226A1 (zh) * 2022-12-27 2024-07-04 北京华昊中天生物医药股份有限公司 含白蛋白结合型优替德隆纳米粒的药物组合物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4319760A1 (de) * 1993-06-15 1994-12-22 Bayer Ag Ipsapiron Arzneimittelzubereitung
EP1353667A1 (en) 2001-01-25 2003-10-22 Bristol-Myers Squibb Company Parenteral formulations containing epothilone analogs
DK1353668T3 (da) * 2001-01-25 2008-06-30 Bristol Myers Squibb Co Fremgangsmåder til fremstillingen af farmaceutiske sammensætninger, der indeholder epothilonanaloger, til behandlingen af cancer
TW200403994A (en) * 2002-04-04 2004-03-16 Bristol Myers Squibb Co Oral administration of EPOTHILONES
US20060134214A1 (en) * 2004-11-18 2006-06-22 Ismat Ullah Enteric coated bead comprising epothilone or epothilone analog, and preparation and administration thereof
BRPI0911482A2 (pt) * 2008-04-24 2017-08-29 Bristol Myers Squibb Co Uso de epotilona d no tratamento de doenças associadas a tau incluindo doenças de alzheimer
CN101362784A (zh) * 2008-10-06 2009-02-11 山东大学 埃博霉素苷类化合物和以其为活性成分的组合物及其应用
CN107041886A (zh) * 2016-02-06 2017-08-15 北京华昊中天生物技术有限公司 脱环氧埃坡霉素衍生物制剂、制备及其治疗肿瘤的应用

Also Published As

Publication number Publication date
ES2981041T3 (es) 2024-10-07
JP7536098B2 (ja) 2024-08-19
EP4062913C0 (en) 2024-05-08
EP4062913B1 (en) 2024-05-08
BR112023003572A2 (pt) 2023-04-04
EP4062913A1 (en) 2022-09-28
AU2021337086B2 (en) 2024-02-29
JP2023508090A (ja) 2023-02-28
PL4062913T3 (pl) 2024-07-22
CA3184960A1 (en) 2022-03-10
CN114727995A (zh) 2022-07-08
CN114727995B (zh) 2024-06-11
WO2022048592A1 (zh) 2022-03-10
EP4062913A4 (en) 2023-01-18
US20230048901A1 (en) 2023-02-16
AU2021337086A1 (en) 2023-02-23
KR20230024389A (ko) 2023-02-20

Similar Documents

Publication Publication Date Title
IL292682A (en) Formulation of x842 for oral administration
ZA201908454B (en) Solid preparation of cariprazine for oral administration
ZA202201541B (en) Oral formulations of edaravone and method of manufacturing thereof
IL304159A (en) A preparation containing bl-8040
EP3597175A4 (en) ORAL COMPOSITION TO PROMOTE DENTAL REMINERALIZATION
IL283593A (en) Bernaflam oral preparations
PL4062913T3 (pl) Stały preparat doustny utidelonu
GB201908109D0 (en) Use of oral chew
GB202114564D0 (en) Oral formulation
IL310652A (en) Radiprodil formulations
IL271658B1 (en) New oral formulations of belinostat
IL268632A (en) Solid formulations of amphotericin B for oral administration
IL312073A (en) Pharmaceutical preparations of aproxypramine
PT3644970T (pt) Novas formulações orais de belinostat
IL313482A (en) Stable formulations of SHR0302
PH22021051421U1 (en) Formulation of breadfruit-jackfruit pie
PH22021051429U1 (en) Formulation of breadfruit-cassava cake
ZA202205263B (en) Solid pharmaceutical forms of perampanel
GB202311981D0 (en) Oral compositions
IL317910A (en) Oral dosage forms of ELRAGLUSIB
GB202315017D0 (en) Powder for oral solution formulations
EP3946639A4 (en) ORAL HYGIENE COMPOSITIONS AND METHODS OF USE THEREOF
ZA202002086B (en) Alcohol-resistant oral pharmaceutical compositions of lorazepam
GB202115571D0 (en) Oral spray composition
GB202101161D0 (en) Formulations for the treatment of tendinopathies